Metropolis Healthcare Limited

NSEI:METROPOLIS 주식 보고서

시가총액: ₹108.3b

Metropolis Healthcare 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Surendran Chemmenkotil

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기1.8yrs
CEO 소유권n/a
경영진 평균 재임 기간1.5yrs
이사회 평균 재임 기간5.3yrs

최근 관리 업데이트

Recent updates

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 14
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Mar 28
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Jan 13
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Dec 23
Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Sep 08
Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Jun 20
Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Feb 13
Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Sep 25
Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Sep 10
Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Jun 07
Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

May 16
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Mar 17
Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Jan 29
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Dec 14
Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Oct 12
Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Aug 27
Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Jul 06
Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

May 28
I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

CEO 보상 분석

Surendran Chemmenkotil 의 보수는 Metropolis Healthcare 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

₹1b

Mar 31 2024n/an/a

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹52m₹13m

₹1b

보상 대 시장: Indian 시장에서 비슷한 규모의 회사에 비해 Surendran 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: Surendran 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.


CEO

Surendran Chemmenkotil

1.8yrs

테뉴어

₹52,318,552

보상

Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...


리더십 팀

이름위치테뉴어보상소유권
Ameera Shah
Executive Chairperson16.5yrs₹47.88m0.35%
₹ 384.0m
Sushil Shah
Founder & Chairman Emeritusno data₹18.00m18.44%
₹ 20.0b
Surendran Chemmenkotil
Chief Executive Officer1.8yrs₹52.32m데이터 없음
Rakesh Agarwal
Chief Financial Officer5yrs₹13.83m데이터 없음
Kannan Alangadan
Chief Operating Officerno data데이터 없음데이터 없음
Kirti Chadha
Chief Scientific & Innovation Officerno data데이터 없음데이터 없음
Pinakin Shah
Chief Information Officerless than a year데이터 없음데이터 없음
Kamlesh Kulkarni
Head of Legal & Secretarial and Compliance Officerless than a year데이터 없음데이터 없음
Jeyasingh Balakrishnan
Head of Public Relations & Corporate Communications3.2yrs데이터 없음데이터 없음
Mohan Menon
Chief Marketing Officer1.3yrs데이터 없음데이터 없음
Ishita Medhekar
Chief People Officer4.8yrs데이터 없음데이터 없음
Nilesh Shah
President of Internal Assurance & Advisor to CEOno data데이터 없음데이터 없음

1.5yrs

평균 재임 기간

경험이 풍부한 관리: METROPOLIS 의 관리팀은 경험 (평균 재직 기간 1.5 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Ameera Shah
Executive Chairperson16.5yrs₹47.88m0.35%
₹ 384.0m
Sushil Shah
Founder & Chairman Emeritus19.3yrs₹18.00m18.44%
₹ 20.0b
Anita Ramachandran
Non-Executive Independent Director4.5yrs₹2.18m데이터 없음
Sanjay Bhatnagar
Non-Executive Independent Director6.2yrs₹1.73m데이터 없음
Vivek Gambhir
Non-Executive Independent Director6.2yrs₹1.85m0.00028%
₹ 303.2k
Ranganathan Subramanian
Independent Directorless than a year₹500.00k데이터 없음
Hemant Sachdev
Non-Executive Independent Director3.5yrs데이터 없음데이터 없음
Aparna Rajadhyaksha
Non-Executive Directorless than a year데이터 없음데이터 없음

5.3yrs

평균 재임 기간

58.5yo

평균 연령

경험이 풍부한 이사회: METROPOLIS 의 이사회경험(평균 재직 기간 5.3 년)으로 간주됩니다.